glp 1 als The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of Full article: Targeting metabolic dysfunction

These trends suggest that GLP-1s are reshaping treatment patterns most significantly in markets where few alternatives exist and where their effectiveness is increasingly valued

GLP-1 medications peri-menopause can increase muscle and bone loss in women

Neurodegenerative diseases, including Alzheimers Disease (AD) and Parkinsons Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system

Rhode Island's Medicaid agency proposes ending GLP-1 coverage for weight loss while keeping diabetes uses, citing soaring costs.

Lemon balm extract supports the gut-brain axis, helping reduce stress-related digestive discomfort for complete digestive wellness

By optimizing your Tirzepatide dosage and monitoring your progress, we ensure that weight loss is not just achieved but sustained over time